Hypaque-m,90% and Radiation skin sensitivity - a phase IV clinical study of FDA data
We study 24 people who take Hypaque-m,90% or have Radiation skin sensitivity. No report of Radiation skin sensitivity is found in people who take Hypaque-m,90%.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Hypaque-m,90%?
Hypaque-m,90% has active ingredients of diatrizoate meglumine; diatrizoate sodium.
What is Radiation Skin Sensitivity?
Radiation skin sensitivity is found to be associated with 63 drugs and 10 conditions by eHealthMe.
Do you take Hypaque-m,90% and have Radiation skin sensitivity?Check whether Radiation skin sensitivity is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Radiation skin sensitivity and when was it recovered:
Expand to all the drugs that have ingredients of diatrizoate meglumine; diatrizoate sodium:
Alternative drugs to, pros and cons of Hypaque-m,90%:
Radiation skin sensitivity treatments and more:
- Radiation skin sensitivity (24 reports)
COVID vaccines that are related to Radiation skin sensitivity:
- Radiation skin sensitivity in Moderna COVID Vaccine
- Radiation skin sensitivity in Pfizer BioNTech Covid Vaccine
- Radiation skin sensitivity in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Radiation skin sensitivity:
All the conditions that are associated with Radiation skin sensitivity:
How the study uses the data?
The study uses data from the FDA. It is based on diatrizoate meglumine; diatrizoate sodium (the active ingredients of Hypaque-m,90%) and Hypaque-m,90% (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ibu and Occult Blood - 7 seconds ago
- Escitalopram and Hypergammaglobulinaemia - 16 seconds ago
- Sporanox and Gastrointestinal Ischaemia - 18 seconds ago
- Diclofenac Potassium and Agitation - 26 seconds ago
- Effexor Xr and Gastrointestinal Disorder - 30 seconds ago
- Adderall 20 vs. B-12 - 32 seconds ago
- Rebif and Eye Pain - 36 seconds ago
- Ethacrynic Acid and Ascites - 39 seconds ago
- Gabapentin and Anorectal Disorder - 48 seconds ago
- Spravato and Adderall drug interaction - a minute ago